Anticholinergic agents for the treatment of "death rattle" in patients with myasthenia gravis

Journal of Pain and Symptom Management

Volumn 26, Issue 1, 2003, Pages 684-686

  Spiess, Jeffrey L ^a,b   Scott, Shane D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b C32 G GH ^*  (United States)

Author keywords

Cholinergic antagonists; Myasthenia gravis; Respiratory sounds; Terminal care

Indexed keywords

ANTIBIOTIC AGENT; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; MORPHINE; PYRIDOSTIGMINE; SCOPOLAMINE;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BRADYCARDIA; BRONCHUS SECRETION; CASE REPORT; COMORBIDITY; DRUG UTILIZATION; DYING; DYSPNEA; FEMALE; FUNGEMIA; HEART FAILURE; HUMAN; HYPEREMIA; HYPOPHARYNX; KIDNEY FAILURE; LEG EDEMA; LEG PAIN; MENTAL HEALTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PLASMAPHERESIS; RESPIRATORY TRACT DISEASE; STOMACH CONTENT; THORAX PAIN; VOMITING;

EID: 0037674936     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(03)00203-3     Document Type: Article

References (10)

1. Strutt R., Fardell B., Chye R. Nebulized glycopyrrolate for drooling in a motor neuron patient. [letter] J Pain Symptom Manage. 23:2002;2-3.
2. Wilders H., Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage. 23:2002;310-317.
3. Victor M., Ropper A.H. Adams and Victor's principles of neurology. seventh edition: 2001;McGraw-Hill, New York.
4. Thomas C.E., Mayer S.A., Gungor Y., et al. Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation. Neurology. 48:1997;1253-1260.
5. Brown J.H., Taylor P. Muscarinic receptor agonists and antagonists. Hardman J.G., Limbird L.E. Goodman & Gilman's the pharmacological basis of therapeutics. tenth edition:2001;155-173 McGraw-Hill, New York.
6. Alaranta S., Klinge E., Pätsi T., et al. Inhibition of nicotine-induced relaxation of the bovine retractor penis muscle by compounds known to have ganglion-blocking properties. Br J Pharmacol. 101:1990;472-476.
7. Szathmary I., Magyar P., Szobor A. Myasthenia gravis: protective effect of ipratropriumbromide (Atrovent) on airways obstruction caused by edrophonium chloride (Tensilon). Eur Neurol. 20:1981;56-61.
8. Liggett S.B., Daughaday C.C., Senior R.M. Ipratropium in patients with COPD receiving cholinesterase inhibitors. Chest. 94:1988;210-212.
9. Marcus E., Wayne F. Myasthenia gravis and glycopyrrolate. [letter] SA Med J. 60:1981;650.
10. Gyawali M.B., Rangedara D.C. Iatrogenically revealed myasthenia gravis. Int J Clin Pract. 53:1999;645.